There are 717 resources available
119MO - Application of an artificial neural network for predicting the chemotherapy benefit of patients with gastric cancer after radical surgery
Presenter: Zhen Xue
Session: Mini oral session on Gastrointestinal tumours 1
Resources:
Abstract
Slides
Webcast
120MO - A phase II study of trifluridine/tipiracil and ramucirumab in patients with unresectable advanced or recurrent gastric cancer
Presenter: Takayuki Ando
Session: Mini oral session on Gastrointestinal tumours 1
Resources:
Abstract
Slides
Webcast
121MO - ctDNA and prognosis in resected esophageal adenocarcinoma (EAC)
Presenter: Emma Ococks
Session: Mini oral session on Gastrointestinal tumours 1
Resources:
Abstract
Slides
Webcast
47MO - Efficacy and quality of life (QOL) in premenopausal Asian patients (pts) with hormone receptor–positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) treated in the MONALEESA (ML)-7 study
Presenter: Yen-Shen Lu
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
48MO - Ribociclib (RIB) + letrozole (LET) in Asian patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2−) advanced breast cancer (ABC): Subgroup analysis of the phase IIIb CompLEEment-1 trial
Presenter: Sanjoy Chatterjee
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
3MO - IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemo in early triple-negative breast cancer (TNBC)
Presenter: Shigehira Saji
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
49MO - IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
Presenter: Hiroji Iwata
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
5MO - Evaluation of pathological complete response (pCR) after neoadjuvant chemo-radiation therapy for primary breast cancer (JCOG0306A1)
Presenter: Tadahiko Shien
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
4MO - Machine learning intratumoral and peritumoral magnetic resonance imaging radiomics for predicting disease-free survival in patients with early-stage breast cancer (RBC-01 Study)
Presenter: Wei Ren
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
Immune checkpoint inhibitors, humble beginnings and back to the future
Presenter: Han Chong Toh
Session: Joint SITC-ESMO Immunotherapy Primer 1
Resources:
Slides
Webcast